Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1979 Feb;35(2):317–323.

Identification of lymphocyte subpopulations in E-RFC-enriched and E-RFC-depleted cell fractions of fresh and cryopreserved lymphocytes.

R L Bolhuis, H R Schuit
PMCID: PMC1537634  PMID: 312177

Abstract

Fresh lymphocytes and frozen-stored lymphocytes were separated into E-RFC-enriched and E-RFC-depleted cell fractions by density gradient centrifugation of sheep red blood cell (SRBC) rosette-forming cells (E-RFC), since the ability to form rosettes is primarily a T cell characteristic. Subpopulations of lymphocytes were identified, demonstrating the presence of cell surface markers: T cell specific antigens (T+), receptors for SRBC on T cells (E-RFC), Fc-receptors (FcR) for IgG type antibodies, and surface Ig (sIg). Our results indicate that, although the E-RFC-depleted fraction contains virtually no cells capable of binding SRBC, there is still a considerable proportion of T cells present in that fraction, as detected with the anti-T cell antiserum. Moreover, data are presented to indicate that the E-RFC-enriched fraction does not consist exclusively of T lymphocytes. Since this separation procedure is used frequently for the identification of the nature of effector cells in cell-mediated (CMC) and antibody-dependent cellular cytotoxicity (ADCC) assays, the identification of T cells in purified lymphocyte fractions by means of SRBC rosette formation may lead to a false conclusion as to the nature of the effector cells.

Full text

PDF
317

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asma G. E., Schuit H. R., Hijmans W. The determination of numbers of T and B lymphocytes in the blood of children and adults by the direct immunofluorescence technique. Clin Exp Immunol. 1977 Aug;29(2):286–294. [PMC free article] [PubMed] [Google Scholar]
  2. Bakács T., Gergely P., Cornain S., Klein E. Characterization of human lymphocyte subpopulations for cytotoxicity against tumor-derived monolayer cultures. Int J Cancer. 1977 Apr 15;19(4):441–449. doi: 10.1002/ijc.2910190402. [DOI] [PubMed] [Google Scholar]
  3. Birnbaum G. Numbers of rosette formine cells in human peripheral blood. Cell Immunol. 1976 Feb;21(2):371–378. doi: 10.1016/0008-8749(76)90066-6. [DOI] [PubMed] [Google Scholar]
  4. Bolhuis R. L., Nooyen A. J. Receptors for IgM and IgM-antigen complexes on human T-lymphocytes reacting with specific anti-human-T-cell antiserum. Immunology. 1977 Nov;33(5):679–687. [PMC free article] [PubMed] [Google Scholar]
  5. Bolhuis R. L., Schuit H. R., Nooyen A. M., Ronteltap C. P. Characterization of natural killer (NK) cells and killer (K) cells in human blood: discrimination between NK and K cell activities. Eur J Immunol. 1978 Oct;8(10):731–740. doi: 10.1002/eji.1830081012. [DOI] [PubMed] [Google Scholar]
  6. Galili U., Klein E., Schlesinger M. Human T lymphocyte receptors for sheep red blood cells and specific antigens: are they identical sites on the cell membrane? J Immunol. 1977 Jul;119(1):104–109. [PubMed] [Google Scholar]
  7. Hersey P., Edwards A., Edwards J., Adams E., Milton G. W., Nelson D. S. Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence for "non-specific" killing by activated T-cells. Int J Cancer. 1975 Jul 15;16(1):173–183. doi: 10.1002/ijc.2910160119. [DOI] [PubMed] [Google Scholar]
  8. Jondal M., Pross H. Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer. 1975 Apr 15;15(4):596–605. doi: 10.1002/ijc.2910150409. [DOI] [PubMed] [Google Scholar]
  9. Kiuchi M., Takasugi M. The nonselective cytotoxic cell (N cell). J Natl Cancer Inst. 1976 Mar;56(3):575–582. doi: 10.1093/jnci/56.3.575. [DOI] [PubMed] [Google Scholar]
  10. Knapp W., Bolhuis R. L., Rádl J., Hijmans W. Independent movement of IgD and IgM molecules on the surface of individual lymphocytes. J Immunol. 1973 Oct;111(4):1295–1298. [PubMed] [Google Scholar]
  11. O'Toole C., Perlmann P., Wigzell H., Unsgaard B., Zetterlund C. G. Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells? Lancet. 1973 May 19;1(7812):1085–1088. doi: 10.1016/s0140-6736(73)90396-6. [DOI] [PubMed] [Google Scholar]
  12. West W. H., Cannon G. B., Kay H. D., Bonnard G. D., Herberman R. B. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells. J Immunol. 1977 Jan;118(1):355–361. [PubMed] [Google Scholar]
  13. West W. H., Sienknecht C. W., Townes A. S., Herberman R. B. Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases. Clin Immunol Immunopathol. 1976 Jan;5(1):60–66. doi: 10.1016/0090-1229(76)90149-5. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES